Green Vision Biotechnology Quick Ratio (GVBT) starting from the second quarter 2022 to second quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Green Vision Biotechnology Corp.  (GVBT)

Green Vision Biotechnology's Quick Ratio

GVBT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2022, Quick Ratio deteriorated to 0 a new company low.

Within Agricultural Production industry 46 other companies have achieved higher Quick Ratio than Green Vision Biotechnology in second quarter 2022. While Quick Ratio total ranking has improved so far during the Q2 2022 to 5937, from total ranking in the first quarter 2022 at 6121.

Explain Quick Ratio?
How much Cash & cash equivalents GVBT´s has?
What are GVBT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GVBT Quick Ratio (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3		 (Jun 30 2021)
Q2
Y / Y Current Liabilities Change -0.82 % 1.88 % 3.71 % 5.92 % 8.15 %
Y / Y Cash & cash equivalent Change -87.46 % -94.91 % -75.66 % -42.62 % 68.74 %
Quick Ratio MRQ 0 0 0 0 0.01
GVBT's Total Ranking # 5937 # 6121 # 6128 # 5309 # 5752
Seq. Current Liabilities Change -2.35 % 0.73 % 1.2 % -0.36 % 0.3 %
Seq. Cash & cash equivalent Change 47.79 % 80.99 % -80.43 % -76.05 % -40.03 %



Quick Ratio second quarter 2022 Company Ranking
Within: No.
Agricultural Production Industry # 47
Consumer Non Cyclical Sector # 215
Overall Market # 5937


Quick Ratio Statistics
High Average Low
3.51 0.19 0
(Jan 31 2014)   (Dec 31 2021)




Financial Statements
Green Vision Biotechnology's Current Liabilities $ 11 Millions Visit GVBT's Balance sheet
Green Vision Biotechnology's Cash & cash equivalent $ 0 Millions Visit GVBT's Balance sheet
Source of GVBT's Sales Visit GVBT's Sales by Geography


Cumulative Green Vision Biotechnology's Quick Ratio

GVBT's Quick Ratio for the trailling 12 Months

GVBT Quick Ratio

 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months		 (Jun 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 2.62 % 4.85 % 6.58 % 6.89 % 5.77 %
Y / Y Cash & cash equivalent TTM Growth -84.85 % -52.23 % 126.53 % 99.18 % 87.38 %
Quick Ratio TTM 0 0 0.01 0.01 0.01
Total Ranking TTM # 5894 # 5315 # 5850 # 3692 # 5853
Seq. Current Liabilities TTM Growth -0.2 % 0.47 % 0.91 % 1.42 % 1.97 %
Seq. Cash & cash equivalent TTM Growth -63.79 % -53.58 % -4.7 % -5.43 % 14.19 %

Quick ratio ranking by company, industry and sector >> Back to GVBT Financial Strength Comparisons >> Go to Compare GVBT Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in GVBT's Current Liabilities to $10.66 millions, cumulative Quick Ratio